CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discount
January 16, 2015 at 17:35 PM EST
Jan 16 (Reuters) - Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.